Allspring Global Investments Holdings, LLC Castle Biosciences Inc Transaction History
Allspring Global Investments Holdings, LLC
- $54.8 Billion
- Q2 2025
A detailed history of Allspring Global Investments Holdings, LLC transactions in Castle Biosciences Inc stock. As of the latest transaction made, Allspring Global Investments Holdings, LLC holds 161,175 shares of CSTL stock, worth $2.63 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
161,175
Previous 217,794
26.0%
Holding current value
$2.63 Million
Previous $4.36 Million
24.52%
% of portfolio
0.01%
Previous 0.01%
Shares
15 transactions
Others Institutions Holding CSTL
# of Institutions
192Shares Held
26.6MCall Options Held
9.5KPut Options Held
5K-
Black Rock Inc. New York, NY3.04MShares$49.7 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.05MShares$33.4 Million0.0% of portfolio
-
Principal Financial Group Inc Des Moines, IA1.47MShares$24 Million0.02% of portfolio
-
Portolan Capital Management, LLC Boston, MA1.27MShares$20.7 Million2.07% of portfolio
-
Dimensional Fund Advisors LP Austin, TX1.2MShares$19.6 Million0.01% of portfolio
About CASTLE BIOSCIENCES INC
- Ticker CSTL
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 26,297,000
- Market Cap $429M
- Description
- Castle Biosciences, Inc., a commercial-stage diagnostics company, focuses to provide diagnostic and prognostic testing services for dermatological cancers. Its lead product is DecisionDx-Melanoma, a multi-gene expression profile (GEP) test to identify the risk of metastasis for patients diagnosed with invasive cutaneous melanoma. The company als...